A Bayesian cost-benefit approach to sample size determination and evaluation in clinical trials
<p>Current practice for sample size computations in clinical trials is largely based on frequentist or classical methods. These methods have the drawback of requiring a point estimate of the variance of treatment effect and are based on arbitrary settings of type I and II errors. They also do...
Prif Awdur: | Kikuchi, T |
---|---|
Awduron Eraill: | Gittins, J |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
2011
|
Pynciau: |
Eitemau Tebyg
-
Bayesian analysis in expert systems
gan: Spiegelhalter, D, et al.
Cyhoeddwyd: (1993) -
An approximate sampling formula under genetic hitchhiking
gan: Etheridge, A, et al.
Cyhoeddwyd: (2006) -
A Bayesian approach to the evolution of metabolic networks on a phylogeny
gan: Mithani, A, et al.
Cyhoeddwyd: (2010) -
Models and software for improving the profitability of pharmaceutical research
gan: Qu, S
Cyhoeddwyd: (2011) -
Synonymous codon usage influences the local protein structure observed
gan: Saunders, R, et al.
Cyhoeddwyd: (2010)